Most Recent

image: Opinion: After We March

Opinion: After We March

By | March 16, 2017

How to become—and stay—involved in science policy 

4 Comments

image: Opinion: Sometimes, Scientists Must March

Opinion: Sometimes, Scientists Must March

By , , and | February 13, 2017

Lessons learned from the “Death of Evidence” demonstration in Canada

9 Comments

image: Opinion: Pay-to-Play Publishing

Opinion: Pay-to-Play Publishing

By | September 3, 2015

Online scientific journals are sacrificing the quality of research articles to make a buck.

3 Comments

image: Opinion: How Postdocs Can Participate

Opinion: How Postdocs Can Participate

By | September 18, 2014

Graduate students and postdoctoral researchers should be taking part in discussions on the future of biomedical research.

6 Comments

image: Opinion: The Pitfalls of Uncertainty

Opinion: The Pitfalls of Uncertainty

By | April 14, 2014

How to successfully inform policy when scientific evidence is not plainly evident.

2 Comments

image: Opinion: Rebuffing RAS Reform

Opinion: Rebuffing RAS Reform

By | September 19, 2013

On the impending changes to the Russian Academy of Sciences

0 Comments

image: Opinion: Marine Canaries in the Coalmine

Opinion: Marine Canaries in the Coalmine

By and | July 18, 2013

Seabirds can serve as indicators of pollution.

0 Comments

image: Opinion: The Payoff of Big Science

Opinion: The Payoff of Big Science

By | June 3, 2013

Was the Human Genome Project the key to a gold mine?

3 Comments

image: Opinion: Does Social Media “Like” Conservation?

Opinion: Does Social Media “Like” Conservation?

By , , , and | April 8, 2013

Environmental issues that resonate on an immediate, emotional level seem to play better on sites like Facebook than do longer-term, but no less serious problems.

3 Comments

image: Opinion: Life as a Target

Opinion: Life as a Target

By | March 27, 2013

Attacks on my work aimed at undermining climate change science have turned me into a public figure. I have come to embrace that role.

33 Comments

Popular Now

  1. Consilience, Episode 3: Cancer, Obscured
  2. RNAi’s Future in Drug-Target Screening
    News Analysis RNAi’s Future in Drug-Target Screening

    A recent CRISPR study contradicted years of RNA interference research on a well-studied cancer drug target. But is it the last nail in the coffin for RNAi as a screening tool? 

  3. A History of Screening for Natural Products to Fight Cancer
  4. Human Cord Plasma Protein Boosts Cognitive Function in Older Mice
AAAS